MedPath

Comparison of the effectiveness of allopurinol and placebo in reducing depressive symptoms in patients with major depressive disorder

Phase 3
Conditions
Condition 1: Major depression. Condition 2: Major depression.
Mild depressive episode
Moderate depressive episode
Registration Number
IRCT201508277373N6
Lead Sponsor
Arak University of Medical Sceinces
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

age 18 to 65 years, diagnosed with major depression based on clinical interviews and diagnostic criteria for DSM V; normal blood levels of uric acid and liver enzymes (ALT, AST)
Exclusion criteria: Serious psychiatric disorders, personality disorders; Taking several drugs simultaneously; severe physical illness; Sensitivity to allopurinol

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath